RecruitingNot ApplicableNCT05297734

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Sponsor

Stanford University

Enrollment

2,996 participants

Start Date

Jun 24, 2022

Study Type

INTERVENTIONAL

Conditions

Cancer End of Life

Summary

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial compares two models of supportive cancer care to find out which better helps patients manage symptoms, emotional well-being, and quality of life after a new cancer diagnosis or recurrence. **You may be eligible if...** - You have a newly diagnosed solid tumor (such as breast, lung, or colon cancer) or a cancer recurrence - You can understand and provide verbal consent - You speak English, Spanish, Chinese, or Vietnamese **You may NOT be eligible if...** - You are unable to give consent - You plan to switch oncologists within the next 12 months - You are employed at the study site - You plan to move within the next 12 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERReceive technology-based supportive cancer care

All participants will receive an electronic health record message or email with standardized information provided regarding advance care planning and symptom management.

BEHAVIORALReceive redesigned team-based supportive cancer care

Lay Health Workers will meet with 1:1 with participants over 12 months to discuss advance care planning, surrogate decision-makers, advance directives and physician orders for life sustaining treatment.

Locations(17)

University of Alabama at Birmingham

Birmingham, Alabama, United States

University of South Alabama

Mobile, Alabama, United States

Beckman Research Institute of City of Hope

Duarte, California, United States

VA Medical Center, Fresno

Fresno, California, United States

Santa Clara Valley Medical Center

Fruitdale, California, United States

St Jude Heritage Medical Group

Fullerton, California, United States

Oncology Institute for Hope and Innovation

Los Angeles, California, United States

Sacramento VA Medical Center - VA Northern California Health Care System

Mather, California, United States

Pacific Cancer Care

Monterey, California, United States

VA Palo Alto

Palo Alto, California, United States

Zuckerberg San Francisco General

San Francisco, California, United States

Kaiser Foundation Research Institute

San Francisco, California, United States

University of San Francisco

San Francisco, California, United States

San Francisco VA Medical Center

San Francisco, California, United States

Spark M. Matsunaga VA Medical Center

Honolulu, Hawaii, United States

North Las Vegas VA Medical Center

Las Vegas, Nevada, United States

George E. Wahlen Department of Veterans Affairs Medical Center

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05297734

Related Trials

Patient-Centered Assessment of Symptoms and Outcomes

NCT039526241 location

Tumor Related Epilepsy

NCT026393251 location

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT055881411 location

Improving Engagement in HIV and Cancer Care in Zimbabwe

NCT069343691 location

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

NCT074543307 locations